Low-grade gliomas in children: single institutional experience in 198 cases
- 9 July 2015
- journal article
- Published by Springer Nature in Child's Nervous System
- Vol. 31 (9) , 1447-1459
Abstract
In pediatric population (0–18 years), low-grade gliomas (PLGG) are the most frequent brain tumors and majority are amenable for surgical removal. A retrospective review of 198 children diagnosed with PLGG between 1980 and 2010 at HSJD was carried out. Several variables were studied to find prognostic factors related to the outcomes (progression-free survival (PFS) and overall survival (OS)). Median age at onset was 88.8 months (3.1 to 214.5 months, SD 53). Surgery was performed in 175 patients (88.4 %), achieving gross total resection (GTR) in 77 (44 %), subtotal resection (STR) in 87 (49.7 %), and 11 (6.3 %) biopsies. Pathological review classified 84 tumors as WHO grade I (48 %) and 89 as grade II (50.8 %). Adjuvant therapy (AT) was given to 75 patients (37.9 %), radiotherapy in 24 (12.1 %), chemotherapy in 33 (16.7 %), and combined in 18 (9.1 %). Sixteen patients (8.1 %) died, 89 (43.4 %) are alive with no evidence of disease, and 93 (47 %) alive with disease, median follow-up 65.2 months. Outcome is significantly correlated with age (p = 0001, worse OS for patients younger than 12 months) and extent of tumor resection (p < 0001). OS for GTR/STR/biopsy was >200, 154.3, and 101.9 months, respectively. Patients treated with AT presented worse OS/PFS (p < 0.001) than those not treated. Histology was non significantly related to outcomes. In our series of PLGG, the best prognostic markers are tumor location (cerebellar) and the extent of tumor resection (GTR). Infants and patients who require adjuvant therapy because of tumor progression or recurrence have worse outcome.Keywords
This publication has 46 references indexed in Scilit:
- Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institutionNeuropathology and Applied Neurobiology, 2013
- Treatment, prognostic factors, and outcomes in spinal cord astrocytomasNeuro-Oncology, 2013
- Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcomeNeuro-Oncology, 2011
- A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)Neuro-Oncology, 2010
- Pediatric Low-Grade GliomasJournal of Child Neurology, 2009
- Outcome and prognostic features in pediatric gliomasCancer, 2009
- Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing DeficitsJournal of Clinical Oncology, 2009
- p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomasNeurochemistry International, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatinNeuro-Oncology, 2007